We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
DHT Holdings
DHT
$3.02B
| $1.9M | ﹤0.01% |
222,826
+1,786
| +0.8% | +$15.6K |
|
|
MODN
1927
DELISTED
MODEL N, INC.
MODN
| $1.9M | ﹤0.01% |
53,705
+3,594
| +7% | +$116K |
|
|
RADI
1928
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $1.9M | ﹤0.01% |
127,414
+8,711
| +7% | +$129K |
|
1929
Oscar Health
OSCR
$8.61B
| $1.89M | ﹤0.01% |
234,943
+49,188
| +26% | +$363K |
|
1930
Herbalife
HLF
$1.29B
| $1.89M | ﹤0.01% |
143,003
-1,460
| -1% | -$19.9K |
|
|
UHT
1931
Universal Health Realty Income Trust
UHT
$594M
| $1.89M | ﹤0.01% |
39,752
+7,377
| +23% | +$339K |
|
1932
Krispy Kreme
DNUT
$577M
| $1.89M | ﹤0.01% |
128,402
+18,696
| +17% | +$280K |
|
|
MODV
1933
DELISTED
ModivCare
MODV
| $1.89M | ﹤0.01% |
41,790
-2,302
| -5% | -$137K |
|
1934
Zentalis Pharmaceuticals
ZNTL
$302M
| $1.88M | ﹤0.01% |
66,800
+2,093
| +3% | +$50.2K |
|
1935
ANI Pharmaceuticals
ANIP
$1.78B
| $1.88M | ﹤0.01% |
34,984
+999
| +3% | +$44.3K |
|
1936
Driven Brands
DRVN
$2.2B
| $1.88M | ﹤0.01% |
69,504
+6,970
| +11% | +$194K |
|
|
HTLF
1937
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.88M | ﹤0.01% |
67,443
+646
| +1% | +$20.1K |
|
1938
Yext
YEXT
$574M
| $1.88M | ﹤0.01% |
165,875
+14,980
| +10% | +$142K |
|
1939
Powell Industries
POWL
$7.71B
| $1.88M | ﹤0.01% |
92,844
-4,140
| -4% | -$71.7K |
|
1940
Relay Therapeutics
RLAY
$4.33B
| $1.86M | ﹤0.01% |
148,406
+12,846
| +9% | +$160K |
|
|
WSR
1941
DELISTED
Whitestone REIT
WSR
| $1.86M | ﹤0.01% |
192,152
-4,299
| -2% | -$38.7K |
|
|
ZEUS
1942
DELISTED
Olympic Steel
ZEUS
| $1.86M | ﹤0.01% |
38,023
+5,837
| +18% | +$274K |
|
1943
Pitney Bowes
PBI
$2.39B
| $1.86M | ﹤0.01% |
525,313
+3,189
| +0.6% | +$11.1K |
|
|
MRTX
1944
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.86M | ﹤0.01% |
51,447
+3,010
| +6% | +$124K |
|
|
MFA
1945
MFA Financial
MFA
$933M
| $1.86M | ﹤0.01% |
165,237
-24,457
| -13% | -$260K |
|
|
TBI
1946
Trueblue
TBI
$311M
| $1.85M | ﹤0.01% |
104,379
-3,038
| -3% | -$51.5K |
|
1947
Dime Commercial Bancshares
DCOM
$1.78B
| $1.84M | ﹤0.01% |
104,546
+3,677
| +4% | +$68.4K |
|
1948
Titan International
TWI
$475M
| $1.83M | ﹤0.01% |
159,613
+8,734
| +6% | +$92.6K |
|
|
EHAB
1949
DELISTED
Enhabit
EHAB
| $1.83M | ﹤0.01% |
159,214
+17,128
| +12% | +$214K |
|
|
NTST
1950
NETSTREIT Corp
NTST
$2.1B
| $1.83M | ﹤0.01% |
102,393
+9,335
| +10% | +$168K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.